Catalyst Pharmaceuticals Inc (CPRX) PE Ratio stood at $40.02: Odds are Looking Good After Recent Activity

As on Thursday, Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) got off with the flyer as it spiked 4.50% to $21.35, before settling in for the price of $20.43 at the close. Taking a more long-term approach, CPRX posted a 52-week range of $11.55-$20.87.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 4106.79%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 74.29%. This publicly-traded company’s shares outstanding now amounts to $107.12 million, simultaneously with a float of $102.43 million. The organization now has a market capitalization sitting at $2.53 billion. At the time of writing, stock’s 50-day Moving Average stood at $18.73, while the 200-day Moving Average is $16.16.

Catalyst Pharmaceuticals Inc (CPRX) Ownership Facts and Figures

Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Catalyst Pharmaceuticals Inc’s current insider ownership accounts for 13.70%, in contrast to 74.93% institutional ownership. According to the most recent insider trade that took place on Aug 21 ’24, this organization’s Director sold 15,000 shares at the rate of 20.10, making the entire transaction reach 301,455 in total value, affecting insider ownership by 348,874. Preceding that transaction, on Aug 20 ’24, Company’s Chief Op. & Scientific Officer sold 150,000 for 20.35, making the whole transaction’s value amount to 3,052,900. This particular insider is now the holder of 675,124 in total.

Catalyst Pharmaceuticals Inc (CPRX) Earnings and Revenue Records

Catalyst Pharmaceuticals Inc’s EPS increase for this current 12-month fiscal period is 74.29% and is forecasted to reach 1.39 in the upcoming year.

Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) Trading Performance Indicators

Let’s observe the current performance indicators for Catalyst Pharmaceuticals Inc (CPRX). It’s Quick Ratio in the last reported quarter now stands at 4.94. The Stock has managed to achieve an average true range (ATR) of 0.67. Alongside those numbers, its PE Ratio stands at $40.02, and its Beta score is 0.76. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 5.83. Similarly, its price to free cash flow for trailing twelve months is now 15.79.

In the same vein, CPRX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.53, a figure that is expected to reach 0.30 in the next quarter, and analysts are predicting that it will be 1.39 at the market close of one year from today.

Technical Analysis of Catalyst Pharmaceuticals Inc (CPRX)

Through scrutinizing the latest numbers posted by the [Catalyst Pharmaceuticals Inc, CPRX], it can be observed that its last 5-days Average volume of 0.95 million was lower the volume of 1.24 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 86.64% While, its Average True Range was 0.67.

Raw Stochastic average of Catalyst Pharmaceuticals Inc (CPRX) in the period of the previous 100 days is set at 99.85%, which indicates a major rise in contrast to 99.58% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 29.19% that was lower than 37.63% volatility it exhibited in the past 100-days period.